This novel project, “Radiomic spatial maps for identifying viable tumor extent on multi-parametric MRI for Glioblastoma,” will be the first to utilize artificial intelligence (AI) to detect hard-to-see glioblastoma tumor edges during a clinical trial....
The WIA is thrilled to announce the 31 finalists for the 2024 awards, recognizing the state’s most innovative and forward-thinking companies and individuals....
A fusion device at the University of Wisconsin–Madison generated plasma for the first time Monday, opening a door to making the highly anticipated, carbon-free energy source a reality....
The Center for Human Genomics and Precision Medicine advances the use of an individual’s genetic information to optimize and guide health care decisions including diagnosis and treatment....
For the 13th consecutive year, U.S. News & World Report ranked University of Wisconsin Hospitals No. 1 in Wisconsin on its Best Hospitals list....
Lynda S. Bader is the director of clinical trials strategic initiatives for the UW Clinical Trials Institute (CTI). She was recently honored with a Regents Academic Staff Excellence Award, the highest recognition bestowed by the Universities of Wisconsin, for her leadership of strategic initiatives that...
Toxoplasma gondii is a parasite responsible for toxoplasmosis, a lifelong chronic infection prevalent in about 30% of the human population. It poses little harm to healthy individuals but can result in severe consequences for immunocompromised people. There is currently no vaccine for Toxoplasma infection, and...
Megan Spurgeon studies the newest identified human tumor virus, called Merkel cell polyomavirus (MCPyV or MCV), which was discovered only about 15 years ago and is implicated in a rare and deadly form of skin cancer....
“I’ve always been really passionate about this type of work because I see the large potential for impact in computing and in electronics,” said Katy Jinkins, (UW-Madison) cofounder and CEO of SixLine Semiconductor. Jinkins is specifically focused on improving semiconductors, the base of chips, which...
Thanks to a recent study from Dan Cappabianca and Krishanu Saha at the Wisconsin Institute for Discovery, Chimeric Antigen Receptor (CAR) T-cell therapy can be improved by altering the conditions the T cells are grown in. And it was all discovered by chance....